The FDA routinely audits clinical research sites, and some of those sites happened to use CRIO eSource on the studies in question. With our broad reach and history as the leading site-adopted eSource solution, we have now established a database of audit results that prove what we’ve known intuitively: CRIO eSource reduces audit risks for...
ASK ME ANYTHING WITH JONATHAN ANDRUS Jonathan Andrus, President & COO at CRIO, is an active thought-leader and presenter in the life sciences industry. He serves on the board and executive committee of the Society for Clinical Data Management (SCDM) and is co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative. In this...
Overview With 9 locations in Texas, California and Louisiana, Benchmark Research is the world’s leading vaccine network. Benchmark has performed over 10,000 studies on over 40,000 subjects and has received numerous awards, including being a five-time recipient of the Best Clinical Trial Site/Network award from the World Vaccine Congress. Challenge Historically, Benchmark used paper charts...
With the recent push toward Decentralized Clinical Trials (DCTs), many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs, investigators and patients these benefits: Reduce errors by ensuring completion of all fields Automated audit trails ensure accuracy of date-times...
BOSTON, MA – August 9, 2022 – CRIO, a Boston-based healthcare technology company streamlining clinical trials for sponsors, sites and patients, announced that it has reached another milestone, exceeding 2,000 clinical research sites standardizing on CRIO’s eSource platform. CRIO supports a variety of clinical trial data. To date, over 800 life science sponsors have data...
CRIO is thrilled to announce the launch of the Study Design Marketplace, CRIO’s product hub for eSource study design templates. Tap in to Team CRIO’s vast experience and explore hundreds of pre-approved templates, curated just for you. Your time is precious. It’s up to you how you spend it. Accelerate the time it takes your...
Clinical Research IO (CRIO)’s recent site survey showed that most sites have recovered business lost during the pandemic, are adjusting to the decentralized clinical trial model, and have implemented their own software in response. At the beginning of the pandemic, CRIO conducted a survey to look at the impact of coronavirus on research sites. By...
For every clinical trial, the sponsor and/or a CRO will conduct a site selection process to determine what research sites are suitable to conduct their trial. A site’s ‘suitability’ is measured by a multitude of factors including but not limited to previous experience conducting clinical trials, research experience for a specific indication, resources available at...
Clinical research coordinators (CRCs) shoulder significant responsibility in the conduct of clinical trials — seeing back-to-back patients, processing labs, completing data entry, responding to emails, liaising with monitors — and play an incredibly important part in the research process. As clinical trial complexity increases and more emphasis is placed on data quality, the demand for...
At the beginning of May 2020, many of the larger pharmaceutical companies released their first quarter financials and shared their plans to open up research amid the ongoing coronavirus crisis. Determined to return to near normal operations by the end of the year, sponsors said they would begin to lift enrollment holds and initiate new studies. According...
Since Clinical Research IO first visited Cytel’s COVID trial tracker in April 2020, the number of treatment and vaccine trials has almost tripled. To date, there are 1,751 COVID studies. Given that the speed of protocol design and study start up has drastically increased throughout the pandemic, we can expect this number to continue rising....
According to the latest survey by Clinical Research IO, clinical trials have largely re-opened. While we should remain optimistic about the restart, Dr. Lindsay McNair, Chief Medical Officer of WCG, reminds us that “we are not post-COVID in many ways.” Given that clinical trials will have to take place amid the ongoing pandemic, “we should...
